GW Pharmaceuticals(NYSE:GWPH) Managements

  • Symbol:NYSE:GWPH
  • Sector:Healthcare
  • Industry:Pharmaceutical
  • CEO:Justin Gover
  • Founded:1998

GW Pharmaceuticals(NYSE:GWPH) Managements

Dr. Geoffrey Guy

Chairman & Founder

Dr. Geoffrey Guy is the founder of GW Pharmaceuticals, and has served as its Chairman since 1998. He is also the creator of Sativex and Epidiolex and continues to lead innovation and new product discovery.

Guy has been actively involved in scientific innovation, medical research and global drug development for his entire career. Prior to his role at GW, Dr Guy served as Chairman and Chief Executive of Ethical Holdings plc, a NASDAQ-quoted drug delivery Company.
Justin Gover

CEO & Executive Director

Justin Gover has served as Chief Executive Officer of GW Pharmaceuticals since January 1999, shortly afer the Company was founded.

He has 21 years’ experience in the pharmaceutical industry, and raised initial rounds of private capital for the company, following which he led its initial public offering on the AIM stock exchange in London in 2001, and more recently led GW’s initial public offering on Nasdaq in 2013.

Chris Tovey

Chief Operating Officer

Chris Tovey has served as Chief Operating Officer of GW Pharmaceuticals since October 2012. He has over 25 years experience in the pharmaceutical industry, and was previously employed at UCB Pharmaceuticals and GlaxoSmithKline plc, where he spent 18 years working in senior commercial roles in both the European and U.K. organisations.

Most recently, Mr. Tovey acted as the Vice President of Global Marketing Operations, where he was responsible for worldwide marketing activities on a portfolio of UCB products generating over €2.0 billion in annual sales.

Investor Presentation

The latest update from the company

Click Here
Stay updated about
this company

Become a Patron below and support us in covering the latest marijuana news!